Genetics of Hearing Loss in Middle Eastern Families
中东家庭听力损失的遗传学
基本信息
- 批准号:7452436
- 负责人:
- 金额:$ 44.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-07 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAmino Acid SequenceBiologyCandidate Disease GeneChromosome MappingChromosomesCochleaCollaborationsDevelopmentES Cell LineEarEnrollmentFamilyFrequenciesGenesGeneticGenome ScanGenotypeGoalsHearingHearing Impaired PersonsHumanIndividualInheritedKnock-in MouseLabyrinthLinkMapsMiddle EastMolecular ProfilingMorphologyMusMutant Strains MiceMutationNamesNonsense MutationNumbersPenetrancePeptide Sequence DeterminationPhenotypePopulationPotassium ChannelProtein IsoformsProteinsRecessive GenesSeriesTestingTranscriptTransforming Protein ERGdeafnesshearing impairmenthuman GJB2 proteinkindredmouse modelmutantnovelpositional cloningsuccess
项目摘要
DESCRIPTION (provided by applicant): The goal of this project is to find and characterize genes responsible for hereditary hearing impairment (HHI) in highly informative Middle Eastern kindreds. Genes identified in these consanguineous families are important to the non-consanguineous U.S. deaf population because all genes for HHI illuminate universal features of hearing biology and because such genes often harbor other mutations leading to recessive or dominant HHI in populations worldwide. We have thus far identified DFNA15 as POU4F3, DFNB30 as MYO3A, and now DFNB28 as a novel isoform of TARA, which we name OTOTARA. We are developing a mouse model of the MYO3A/DFNB30 nonsense mutation. In two other kindreds, we mapped genes for hearing loss to small intervals on chromosomes 2q31 and 11q14.3-q21. These regions do not harbor known deafness genes, so these kindreds will reveal two more novel genes for HHI. In four other families, we identified new alleles of known deafness genes, suggesting that genetic hearing loss in this population is similar to that elsewhere. In the 156 families with HHI enrolled in our project, GJB2 (connexin 26) is responsible for HHI in only 17 (11%) of families, reflecting the high frequency of HHI due to other genes. In the next cycle of this project, our collaboration proposes:
(1) to further characterize wildtype and mutant OTOTARA
(2) to identify genes for recessive, nonsyndromic HHI on chromosomes 2q31 and 11q14.3-q21
(3) to undertake positional identification of genes for HHI in four additional kindreds
(4) to complete the MYO3A/DFNB30 knock-in mouse and characterize its phenotype
The strengths of this collaboration are the enthusiastic participation in the project of extended informative kindreds with HHI, the large number of these kindreds likely to carry mutations in heretofore unknown hearing-related genes, and our demonstrated success in mapping, identifying, and characterizing genes for HHI in these families.
描述(由申请人提供):该项目的目标是发现和表征在高度信息化的中东地区的遗传性听力障碍(HHI)的基因。在这些近亲家庭中发现的基因对于非近亲的美国聋人群体很重要,因为HHI的所有基因都阐明了听力生物学的普遍特征,并且因为这些基因经常携带其他突变,导致世界各地人群中隐性或显性HHI。到目前为止,我们已经将DFNA 15鉴定为POU 4F 3,DFNB 30鉴定为MYO 3A,并且现在将DFNB 28鉴定为塔拉的新同种型,我们将其命名为OTO塔拉。我们正在开发MYO 3A/DFNB 30无义突变的小鼠模型。在另外两个kinetics中,我们将听力损失的基因定位到染色体2 q31和11q14.3-q21上的小间隔。这些区域没有已知的耳聋基因,因此这些激酶将揭示两个新的HHI基因。在另外四个家庭中,我们发现了已知耳聋基因的新等位基因,这表明该人群的遗传性听力损失与其他地方相似。在我们的项目中登记的156个HHI家庭中,GJB 2(连接蛋白26)仅在17个(11%)家庭中负责HHI,反映了由于其他基因导致的HHI的高频率。在该项目的下一个周期,我们的合作建议:
(1)为了进一步表征野生型和突变型OTOTARA,
(2)确定染色体2 q31和11q14.3-q21上隐性、非综合征HHI的基因
(3)在另外四个基因组中进行HHI基因的定位鉴定
(4)完成MYO 3A/DFNB 30基因敲入小鼠并表征其表型
这种合作的优势是在项目中的热情参与扩展的信息kinetics与HHI,大量的这些kinetics可能携带突变,在迄今为止未知的听力相关基因,和我们证明成功的映射,识别和表征基因HHI在这些家庭。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY-CLAIRE KING其他文献
MARY-CLAIRE KING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY-CLAIRE KING', 18)}}的其他基金
1/3 Genomics of Schizophrenia in the South African Xhosa
1/3 南非科萨人精神分裂症的基因组学
- 批准号:
10322744 - 财政年份:2021
- 资助金额:
$ 44.26万 - 项目类别:
Whole Genome Sequencing and Transcriptome Analysis in Schizophrenia Cases and Controls from the Xhosa Population
科萨族精神分裂症病例和对照的全基因组测序和转录组分析
- 批准号:
9250897 - 财政年份:2016
- 资助金额:
$ 44.26万 - 项目类别:
GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER
遗传性乳腺癌和卵巢癌的基因组分析
- 批准号:
9123570 - 财政年份:2015
- 资助金额:
$ 44.26万 - 项目类别:
GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER
遗传性乳腺癌和卵巢癌的基因组分析
- 批准号:
10222586 - 财政年份:2015
- 资助金额:
$ 44.26万 - 项目类别:
GENOMIC ANALYSIS OF INHERITED BREAST AND OVARIAN CANCER
遗传性乳腺癌和卵巢癌的基因组分析
- 批准号:
9751788 - 财政年份:2015
- 资助金额:
$ 44.26万 - 项目类别:
COMPLETE VARIANT PROFILING OF ALL KNOWN BREAST CANCER GENES
所有已知乳腺癌基因的完整变异分析
- 批准号:
8630707 - 财政年份:2013
- 资助金额:
$ 44.26万 - 项目类别:
COMPLETE VARIANT PROFILING OF ALL KNOWN BREAST CANCER GENES
所有已知乳腺癌基因的完整变异分析
- 批准号:
9330794 - 财政年份:2013
- 资助金额:
$ 44.26万 - 项目类别:
2/3-GENOMICS OF SCHIZOPHRENIA IN THE SOUTH AFRICAN XHOSA
2/3-南非科萨人精神分裂症的基因组学
- 批准号:
8436081 - 财政年份:2013
- 资助金额:
$ 44.26万 - 项目类别:
2/3 Genomics of Schizophrenia in the South African Xhosa
2/3 南非科萨人精神分裂症的基因组学
- 批准号:
9075382 - 财政年份:2013
- 资助金额:
$ 44.26万 - 项目类别:
2/3-GENOMICS OF SCHIZOPHRENIA IN THE SOUTH AFRICAN XHOSA
2/3-南非科萨人精神分裂症的基因组学
- 批准号:
8987596 - 财政年份:2013
- 资助金额:
$ 44.26万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 44.26万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 44.26万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 44.26万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 44.26万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 44.26万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 44.26万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 44.26万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 44.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 44.26万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 44.26万 - 项目类别: